Cellular and Humoral Immunogenicity of a Candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1

The urgent need for effective, safe and equitably accessible vaccines to tackle the ongoing spread of COVID-19 led researchers to generate vaccine candidates targeting varieties of immunogens of SARS-CoV-2. Because of its crucial role in mediating binding and entry to host cell and its proven safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Alluhaybi, Khalid A., Alharbi, Rahaf H., Alhabbab, Rowa Y., Aljehani, Najwa D., Alamri, Sawsan S., Basabrain, Mohammad, Alharbi, Rehaf, Abdulaal, Wesam H., Alfaleh, Mohamed A., Tamming, Levi, Zhang, Wanyue, Hassanain, Mazen, Algaissi, Abdullah, Abuzenadah, Adel M., Li, Xuguang, Hashem, Anwar M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402341/
https://www.ncbi.nlm.nih.gov/pubmed/34451977
http://dx.doi.org/10.3390/vaccines9080852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402341/
https://www.ncbi.nlm.nih.gov/pubmed/34451977
http://dx.doi.org/10.3390/vaccines9080852

Ejemplares similares